Search


Vor Bio is trying to help AML patients who receive a stem cell transplant to be more amenable to follow-on therapies - they just had key PoC data
President and CEO Robert Ang describes how Vor knocks out CD33 in transplant cells before they are administered so that patients can...
Oct 2, 2024








.png)




